Manufacturing Market Continuous by Roots Analysis



It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

Press Release

Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing

Roots Analysis is pleased to announce the publication of its recent study, titled, “Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030.”

report –

Transcripts of interviews held with the following senior level representatives of stakeholder companies
Andrea Adamo, Founder and Chief Executive Officer, Zaiput Flow technologies
Bayan Takizawa, Co-Founder and Chief Business Officer, CONTINUUS Pharmaceuticals
Nick Thomson, Senior Director Chemical Research and Development, Pfizer
Himanshu Gadgil, Director and Chief Scientific Officer, Enzene Biosciences
Eric Fang, Chief Scientific Officer, Snapdragon Chemistry)
Ian Houson, Technical Project Manager, Continuous Manufacturing and Crystallization, University of Strathclyde

Key companies covered in the report

AbbVie Contract Manufacturing
Ajinomoto Bio-Pharma Services
Boehringer Ingelheim BioXcellence
SK biotek
WuXi AppTec

For more information please click on the following link:

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

Facebook –

LinkedIn –

Twitter –